Olav Hungnes

4.2k total citations
86 papers, 3.0k citations indexed

About

Olav Hungnes is a scholar working on Epidemiology, Infectious Diseases and Agronomy and Crop Science. According to data from OpenAlex, Olav Hungnes has authored 86 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Epidemiology, 46 papers in Infectious Diseases and 11 papers in Agronomy and Crop Science. Recurrent topics in Olav Hungnes's work include Influenza Virus Research Studies (48 papers), Respiratory viral infections research (42 papers) and SARS-CoV-2 and COVID-19 Research (25 papers). Olav Hungnes is often cited by papers focused on Influenza Virus Research Studies (48 papers), Respiratory viral infections research (42 papers) and SARS-CoV-2 and COVID-19 Research (25 papers). Olav Hungnes collaborates with scholars based in Norway, Sweden and Netherlands. Olav Hungnes's co-authors include Susanne Dudman, Angie Lackenby, Adam Meijer, Maria Zambon, Alan Hay, Anette Kilander, Rikard Rykkvin, Bjørn Grinde, Brunhilde Schweiger and Sylvie van der Werf and has published in prestigious journals such as Nature Communications, Blood and Annals of Internal Medicine.

In The Last Decade

Olav Hungnes

84 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olav Hungnes Norway 30 2.1k 1.0k 509 504 302 86 3.0k
Francisco Pozo Spain 33 2.6k 1.2× 1.2k 1.2× 234 0.5× 237 0.5× 215 0.7× 148 3.3k
Truong Huu Khanh Vietnam 11 2.2k 1.0× 1.1k 1.1× 874 1.7× 430 0.9× 545 1.8× 22 2.9k
Joanna Ellis United Kingdom 38 3.3k 1.5× 1.7k 1.7× 400 0.8× 573 1.1× 401 1.3× 115 4.8k
Vo Minh Hien Vietnam 10 2.3k 1.1× 1.1k 1.0× 902 1.8× 414 0.8× 515 1.7× 12 2.9k
Marilda Mendonça Siqueira Brazil 31 2.0k 0.9× 1.4k 1.3× 255 0.5× 308 0.6× 102 0.3× 183 3.3k
John H. Beigel United States 22 1.6k 0.8× 1.1k 1.1× 512 1.0× 393 0.8× 294 1.0× 53 2.8k
Phan Tu Qui Vietnam 12 2.2k 1.0× 1.1k 1.1× 868 1.7× 415 0.8× 477 1.6× 19 3.0k
A.M. Palache Netherlands 33 2.7k 1.3× 818 0.8× 1.1k 2.2× 453 0.9× 278 0.9× 59 3.4k
Pilaipan Puthavathana Thailand 27 2.7k 1.3× 1.8k 1.7× 693 1.4× 393 0.8× 1.2k 3.9× 136 3.8k
W.E.P. Beyer Netherlands 27 3.2k 1.5× 1.3k 1.3× 924 1.8× 359 0.7× 809 2.7× 53 3.8k

Countries citing papers authored by Olav Hungnes

Since Specialization
Citations

This map shows the geographic impact of Olav Hungnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olav Hungnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olav Hungnes more than expected).

Fields of papers citing papers by Olav Hungnes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olav Hungnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olav Hungnes. The network helps show where Olav Hungnes may publish in the future.

Co-authorship network of co-authors of Olav Hungnes

This figure shows the co-authorship network connecting the top 25 collaborators of Olav Hungnes. A scholar is included among the top collaborators of Olav Hungnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olav Hungnes. Olav Hungnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fossum, Even, Anna Hayman Robertson, Asia‐Sophia Wolf, et al.. (2025). Low Levels of Neutralizing Antibodies Against SARS‐CoV‐2 KP.3.1.1 and XEC in Serum From Seniors in May 2024. Influenza and Other Respiratory Viruses. 19(5). e70102–e70102. 2 indexed citations
2.
Paulsen, Katrine M., Olav Hungnes, Kristian Alfsnes, et al.. (2025). A Retrospective Sero-Surveillance Study for Antibodies Against Tick-Borne Encephalitis Virus in Norway. Viruses. 17(3). 291–291.
3.
4.
Fossum, Even, et al.. (2023). Poor neutralizing antibody responses against SARS‐CoV‐2 Omicron BQ.1.1 and XBB in Norway in October 2022. Influenza and Other Respiratory Viruses. 17(6). e13144–e13144. 7 indexed citations
5.
Veneti, Lamprini, Sara Viksmoen Watle, Jostein Starrfelt, et al.. (2023). Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022. International Journal of Infectious Diseases. 130. 182–188. 12 indexed citations
6.
Kristoffersen, Anja Bråthen, Håkon Bøås, Lamprini Veneti, et al.. (2022). Milder disease trajectory among COVID-19 patients hospitalised with the SARS-CoV-2 Omicron variant compared with the Delta variant in Norway. Scandinavian Journal of Public Health. 50(6). 676–682. 12 indexed citations
7.
Kared, Hassen, Asia‐Sophia Wolf, Anthony Ravussin, et al.. (2022). Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults. Nature Communications. 13(1). 4165–4165. 41 indexed citations
8.
Bøås, Håkon, Terese Bekkevold, Anne‐Marte Bakken Kran, et al.. (2022). The burden of hospital-attended influenza in Norwegian children. Frontiers in Pediatrics. 10. 963274–963274. 2 indexed citations
9.
Veneti, Lamprini, Elina Seppälä, Jostein Starrfelt, et al.. (2021). No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway. International Journal of Infectious Diseases. 115. 178–184. 22 indexed citations
10.
Laake, Ida, Gro Tunheim, Anna Hayman Robertson, et al.. (2018). Risk of pregnancy complications and adverse birth outcomes after maternal A(H1N1)pdm09 influenza: a Norwegian population-based cohort study. BMC Infectious Diseases. 18(1). 525–525. 16 indexed citations
11.
Tambs, Kristian, Kristin Gustavson, Synnve Schjølberg, et al.. (2018). Early prenatal exposure to pandemic influenza A (H1N1) infection and child psychomotor development at 6 months – A population-based cohort study. Early Human Development. 122. 1–7. 12 indexed citations
12.
13.
Gjerset, Britt, et al.. (2013). Swine influenza in Norway: a distinct lineage of influenza A(H1N1)pdm09 virus. Influenza and Other Respiratory Viruses. 7(s4). 21–26. 3 indexed citations
14.
Yri, Olav Erich, Dag Torfoss, Olav Hungnes, et al.. (2011). Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment. Blood. 118(26). 6769–6771. 119 indexed citations
15.
Zucs, P, B C Ciancio, Olav Hungnes, et al.. (2009). Start of the influenza season 2008-9 in Europe - increasing influenza activity moving from West to East dominated by A(H3N2). Eurosurveillance. 14(3). 9 indexed citations
16.
Hauge, Siri Helene, Hege Salvesen Blix, Katrine Borgen, et al.. (2009). Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007–08. Virology Journal. 6(1). 54–54. 11 indexed citations
17.
Bergsaker, Marianne A. Riise, Olav Hungnes, & Bjørn G Iversen. (2006). Influensavaksinering – hvorfor, for hvem og med hvilken vaksine?. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
18.
19.
20.
Jonassen, Tom Øystein, Einar S. Berg, Olav Hungnes, et al.. (1997). Sequence Analysis of HIV-1 Group O from Norwegian Patients Infected in the 1960s1. Virology. 231(1). 43–47. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francisco Pozo Breakdown of academic impact, for papers by Truong Huu Khanh Breakdown of academic impact, for papers by Joanna Ellis Breakdown of academic impact, for papers by Vo Minh Hien Breakdown of academic impact, for papers by Marilda Mendonça Siqueira Breakdown of academic impact, for papers by John H. Beigel Breakdown of academic impact, for papers by Phan Tu Qui Breakdown of academic impact, for papers by A.M. Palache Breakdown of academic impact, for papers by Pilaipan Puthavathana Breakdown of academic impact, for papers by W.E.P. Beyer
Rankless by CCL
2026